Clade Therapeutics

📍 Boston, United States👥 16 employees💰 Last funded Dec 2021
Biotechnology Research🌐 cladetx.com
Website LinkedIn
Clade Therapeutics is a well-funded cell therapy company developing novel cell-based medicines for the treatment of cancer and other devastating diseases. The company, located in the heart of Cambridge was recently launched by an exceptional group of academic leaders and successful bioentrepreneurs converging stem cell biology, immunology, regenerative medicine, and gene editing into the next-generation of stem cell-derived medicines.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
United Kingdom
1
Frequently asked questions
Who invested in Clade Therapeutics?
Clade Therapeutics has 2 investors on record on gritt.io.
When did Clade Therapeutics last raise funding?
The most recent investment in Clade Therapeutics recorded on gritt.io was in December 2021.
What industry is Clade Therapeutics in?
Clade Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Clade Therapeutics based?
Clade Therapeutics is headquartered in Boston, United States.